Skip to content
★ Sign in to follow
JG

John Gorman

Executive
Zivo Bioscience, Inc.
Total declarations
5
Company
1
▲ Purchases (3 ops.)
€1.2B
▼ Sales (0 ops.)
—

Latest filing published 20 Jun 2013 for Zivo Bioscience, Inc., €56k.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 20 Jun 2013 · 4890 days ago · €18k
    -48.6%
    Entry US$168.00 · Close at T+365 US$86.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

John Gorman: trading record in brief

John Gorman discloses dealings in Zivo Bioscience, Inc. to SEC (Form 4). In total, 5 filings cover trades dated from 28 January 2009 to 18 June 2013.

Every open-market trade on record is a purchase: 3 purchases worth €1.2B, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 1 option exercise. Since January 2013: 1 purchase and no sales on the market.

Half of the purchases are above €18k and half below.

The latest filing, published on 20 June 2013, reports an option exercise of €56k in Zivo Bioscience, Inc. The clock since the last published purchase (20 June 2013) now reads 4,890 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to John Gorman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◇
    EVP OperationsExecutivesZivo Bioscience, Inc.
    75,000 USD0SEC
    500,000 shares@ US$0.15Common StockSEC:0001078782-13-001245:0
  • ◆
    EVP OperationsExecutivesZivo Bioscience, Inc.
    75,000 USD0SEC
    195,313 shares@ US$0.384Common StockSEC:0001078782-13-001245:1
  • ▲
    EVP OperationsExecutivesZivo Bioscience, Inc.
    23,967 USD0SEC
    61,000 shares@ US$0.3929Common StockSEC:0001078782-13-001245:2
    Canonical exit: 16 Sept 2013 (T+90)
  • ▲
    DirectorExecutivesZivo Bioscience, Inc.
    2B USD0SEC
    186,512 shares@ US$9,326.00Common stockSEC:0001078782-09-000915:0
    Canonical exit: 6 Sept 2009 (T+90)
  • ▲
    DirectorExecutivesZivo Bioscience, Inc.
    20,000 USD0SEC
    400,000 shares@ US$0.05Common StockSEC:0001078782-09-000085:0
    Canonical exit: 28 Apr 2009 (T+90)

5 of 5 declarations